Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse

Cephalalgia

Volumn 23, Issue 10, 2003, Pages 963-971

  Williams, D R ^a   Stark, R J ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Analgesic induced headache; Chronic daily headache; Lidocaine; Lignocaine; Rebound headache

Indexed keywords

ANALGESIC AGENT; CODEINE; ERGOTAMINE; LIDOCAINE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ANALGESIC AGENT ABUSE; CHRONIC DISEASE; DRUG ABUSE; DRUG EFFICACY; DRUG INFUSION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; REBOUND; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALGESICS; CLINICAL TRIALS; FEMALE; HEADACHE DISORDERS; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0346328621     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00623.x     Document Type: Review

References (46)

1. Scher AI, Stewart WF, Liberman J. Lipton. Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506.
2. Castillo J, Munoz P, Guitera V. Pascual. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-6.
3. Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN et al. Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology 2000; 54:314-9.
4. Mathew NT. Neurobiology of transformed migraine. Introduction and clinical presentation. In: Proceedings of the 40th Annual Scientific Meeting of the American Association for the Study of Headache 1998:13-20.
5. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13:277-83.
6. Wilkinson M. Introduction. In: Diener HC, Wilkinson M, editors. Drug Induced Headache. Berlin: Springer, 1988:1.
7. Barone-Kaganas I. Der medikamenteninduzierte Kopfschmerz und seine Behandlung. Schweiz Med Wochenschrift 1999; 129:446-9.
8. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982; 33:335-41.
9. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache, long-term results of withdrawal therapy. J Neurol 1989; 236:9-14.
10. Schnider P, Aull S, Baumgartner Ch, Tribl GG, Schnider P, Wober C et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up study. Cephalalgia 1996; 16:481-5.
11. Tribl GG, Schnider P, Wober C, Auterith A, Zeiler K, Wessely P. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001; 21:691-6.
12. Drucker P, Tepper S. Daily sumatriptan for detoxification from rebound. Headache 1998; 38:687-90.
13. Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991; 31:71-4.
14. Descombes S, Brefel-Courbon C, Thalamas C, Albucher JF, Rascol O, Montastruc JL. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache 2001; 41:178-82.
15. Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000; 20:658-62.
16. Saper JR, Silberstein SD, Lake AE, Winters ME. Double blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994; 34:497-502.
17. Foster CA, Bafaloukos J. Paroxetine in the treatment of chronic daily headache. Headache 1994; 34:587-9.
18. Robbins L. Daily methadone for severe chronic daily headache [abstract]. Headache 1995; 35:288.
19. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000; 20:107-13.
20. Silberstein SD, Silberstein JR. Chronic daily headache: Long-term prognosis following inpatient treatment with repetitive IV DHE. Headache 1992; 32:439-45.
21. Pringsheim T, Howse D. In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study. Can J Neurol Sci 1998; 25:146-50.
22. Nicolodi M, Del Bianco PL, Sicuteri F. Histamine therapy of chronic daily headache having the features of transformed migraine [abstract]. Cephalalgia 1998; 18:410.
23. Kaube H, Hoskin KL, Goadsby PJ. Lignocaine is effective in chronic headache by inhibition of central trigeminal neurons [abstract]. Cephalalgia 1993; 12:234.
24. Hand P, Stark R. Intravenous lignocaine infusions for severe chronic daily headache. Med J Aust 2000; 172:157-9.
25. Silberstein SD. Chronic daily headache, diagnosis and treatment. In: Silberstein SD, Lipton RB, Goadsby PJ, editors Headache in Clinical Practice. Oxford: Isis Medical Media, 1998: 101-14.
26. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57:1694-8.
27. Ala-Hurul V, Myllyla V, Hokkanen E. Ergotamine abuse, results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia 1982; 2:189-95.
28. Tfelt-Hansen P, Ebelholt Krabbe A. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1981; 1:29-32.
29. Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K et al. Long-term outcome of patients with headache and drug abuse after in patient withdrawal: five-year follow-up. Cephalalgia 1996; 16:481-5.
30. Redillas C, Solomon S. Prophylactic pharmacological treatment of chronic daily headache. Headache 2000; 40:83-102.
31. Reutens DC, Fatovich DM, Stewart-Wynne EG, Prentice DA. Is intravenous lidocaine clinically effective in acute migraine? Cephalalgia 1991; 11:245-7.
32. Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000; 87:7-17.
33. Heinz A, Denke C, Ernst G. Medikamenteninduzierter Kopfschmerz. Schmerz 1999; 13:304-14.
34. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998; 79:964-82.
35. Yamamura H, Malick A, Chamberlin NL, Burstein R. Cardiovascular and neuronal responses to head stimulation reflect central sensitizatison and cutaneous allodynia in a rat model of migraine. J Neurophysiol 1999; 81:479-93.
36. Max MB, Hagen NA. Do changes in brain sodium channels cause central pain? Neurology 2000; 54:544.
37. Hering R, Gardiner I, Catarci T, Whitmarsh T, Steiner T, de Belleroche J. Cellular adaptation in migraineurs with chronic daily headache. Cephalalgia 1993; 13:261-6.
38. Srikiatkhachorn A. Pathophysiology of chronic daily headache. Curr Pain Headache Report 2001; 5:537-44.
39. Chaplan SR, Bach FW, Shafer SL, Yaksh TL. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology 1995; 83:775-85.
40. Borgland SL. Acute opioid receptor desensitization and tolerance: is there a link? Clin Ex Pharmacol Physiol 2001; 28:147-54.
41. Rapoport AM, Weeks RE, Sheftell FD, Baskin SM, Verdi J. The 'analgesic washout period', a critical variable in the evaluation of headache treatment efficacy. Neurology 1986; 36 Suppl 1:100-1.
42. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache 1990; 30:634-8.
43. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337:1442-3.
44. Lake A, Saper J, Madden S, Kreeger C. Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study. Headache 1993; 33:55-62.
45. Lu SR, Fuh JL, Juang KD, Wang SJ. Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache 2000; 40:724-9.
46. Warner JS. The outcome of treating patients with suspected rebound headache. Headache 2001; 41:685-92.